Met Life Investment Management, LLC Aldeyra Therapeutics, Inc. Transaction History

Met Life Investment Management, LLC

$20.1 Billion
Q3 2025

A detailed history of Met Life Investment Management, LLC transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 18,397 shares of ALDX stock, worth $93,272. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,397

Previous 28,332 35.07%

Holding current value

$93,272

Previous $108,000 12.04%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$4.0 - $5.89 $39,740 - $58,517	-9,935 Reduced 35.07%	18,397 $95,000
Q2 2025 Aug 13, 2025	BUY	$1.42 - $5.48 $330 - $1,276	233 Added 0.83%	28,332 $108,000
Q1 2025 May 14, 2025	SELL	$4.7 - $6.98 $2,773 - $4,118	-590 Reduced 2.06%	28,099 $161,000
Q2 2024 Aug 13, 2024	BUY	$3.25 - $4.72 $12,619 - $18,327	3,883 Added 15.65%	28,689 $94,000
Q1 2024 May 14, 2024	BUY	$2.77 - $4.22 $68,712 - $104,681	24,806 New	24,806 $81,000

Q3 2023 May 09, 2024	BUY	$6.11 - $8.16 $150,800 - $201,396	24,681 New	24,681 $164,000
Q2 2023 Apr 29, 2024	BUY	$7.11 - $11.89 $175,481 - $293,457	24,681 New	24,681 $207,000
Q2 2023 Aug 10, 2023	BUY	$7.11 - $11.89 $175,481 - $293,457	24,681 New	24,681 $207,000
Q2 2022 Aug 11, 2022	SELL	$2.43 - $4.85 $34,775 - $69,408	-14,311 Closed	0 $0
Q1 2022 May 10, 2024	BUY	$3.25 - $5.17 $46,510 - $73,987	14,311 New	14,311 $63,000
Q1 2022 Jun 20, 2023	BUY	$3.25 - $5.17 $46,510 - $73,987	14,311 New	14,311 $63,000
Q1 2022 Mar 22, 2023	SELL	$3.25 - $5.17 $14,313 - $22,768	-4,404 Reduced 23.53%	14,311 $63,000
Q1 2022 May 12, 2022	SELL	$3.25 - $5.17 $14,313 - $22,768	-4,404 Reduced 23.53%	14,311 $64,000
Q4 2021 May 17, 2024	BUY	$3.5 - $9.63 $32,543 - $89,539	9,298 Added 98.74%	18,715 $74,000
Q4 2021 Jun 21, 2023	BUY	$3.5 - $9.63 $65,502 - $180,225	18,715 New	18,715 $74,000
Q4 2021 Mar 22, 2023	BUY	$3.5 - $9.63 $32,543 - $89,539	9,298 Added 98.74%	18,715 $74,000
Q4 2021 Feb 15, 2022	BUY	$3.5 - $9.63 $32,543 - $89,539	9,298 Added 98.74%	18,715 $75,000
Q3 2021 May 17, 2024	SELL	$7.94 - $11.31 $76,438 - $108,881	-9,627 Reduced 50.55%	9,417 $82,000
Q3 2021 Jun 21, 2023	BUY	$7.94 - $11.31 $74,770 - $106,506	9,417 New	9,417 $82,000
Q3 2021 Mar 22, 2023	SELL	$7.94 - $11.31 $76,438 - $108,881	-9,627 Reduced 50.55%	9,417 $82,000
Q3 2021 Nov 15, 2021	SELL	$7.94 - $11.31 $76,438 - $108,881	-9,627 Reduced 50.55%	9,417 $83,000
Q2 2021 May 17, 2024	SELL	$10.44 - $14.85 $60,155 - $85,565	-5,762 Reduced 23.23%	19,044 $215,000
Q2 2021 Jun 21, 2023	BUY	$10.44 - $14.85 $198,819 - $282,803	19,044 New	19,044 $215,000
Q2 2021 Mar 22, 2023	BUY	$10.44 - $14.85 $198,819 - $282,803	19,044 New	19,044 $215,000
Q2 2021 Aug 16, 2021	BUY	$10.44 - $14.85 $198,819 - $282,803	19,044 New	19,044 $216,000

Others Institutions Holding ALDX

# of Institutions

143

Shares Held

39.9M

Call Options Held

344K

Put Options Held

71.7K

View Full List

About Aldeyra Therapeutics, Inc.

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $296M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

More about ALDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account

Met Life Investment Management, LLC Aldeyra Therapeutics, Inc. Transaction History